Filtros de búsqueda

Lista de obras de Gianluca Gaidano

'Role of bone marrow stromal cells in the growth of human multiple myeloma ⬇️

artículo científico publicado el 15 de junio de 1991

-Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1

artículo científico publicado en 2020

13q14 Chromosome Deletion Size and Number of Deleted Cells Influence Prognosis In Chronic Lymphocytic Leukemia ⬇️

scholarly article

13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia

artículo científico

14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia

artículo científico publicado en 2008

A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.

artículo científico publicado en 2018

A MALT lymphoma prognostic index generated from the dataset of the IELSG-19 prospective clinical trial

artículo científico

A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado en 2014

A Multi-Center Phase I/II Study of Melphalan, Prednisone, Thalidomide and Defibrotide in Avanced Multiple Myeloma Patients. ⬇️

artículo científico publicado en 2006

A Multicenter, Open Label Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (MM) Patients ⬇️

scholarly article

A Phase II Trial of Rituximab-CHOP Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (90Y-IT) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients. ⬇️

artículo científico publicado en 2009

A Phase IIa, Open-Label, Multicenter Study of Single-Agent Tafasitamab (MOR208), an Fc-Optimized Anti-CD19 Antibody, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma: Long-Term Follow-up, Final Analysis ⬇️

artículo científico publicado en 2019

A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression ⬇️

scholarly article

A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients ⬇️

artículo científico publicado en 2011

A Prospective, Randomized, Phase III Study of Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Versus Bortezomib, Melphalan and Prednisone (VMP) in Elderly Newly Diagnosed Myeloma Patients ⬇️

artículo científico publicado en 2008

A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

scientific article published on 14 August 2019

A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation

artículo científico publicado en 2022

A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia

artículo científico publicado en 2015

A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.

artículo científico publicado en 2015

A step ahead toward precision medicine for chronic lymphocytic leukemia

artículo científico publicado en 2020

A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome

article

AIDS-related extranodal non-Hodgkin's lymphomas with plasma cell differentiation ⬇️

artículo científico publicado el 1 de agosto de 1997

ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles ofTP53disrupted chronic lymphocytic leukaemia cells

article

ATM and chronic lymphocytic leukemia: mutations, and not only deletions, matter

artículo científico publicado en 2012

Aberrant Methylation of SHP-1 (SH2-Containing Phosphatases 1) and SOCS-1 (Suppressor of Cytokine Signalling 1) Genes in Immunodeficiency-Related Lymphomas. ⬇️

scholarly article

Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas

artículo científico publicado en 2004

Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.

artículo científico publicado en 2004

Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma

artículo científico publicado en 2003

Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders.

artículo científico publicado en 2004

Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma.

artículo científico publicado en 2006

Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma

artículo científico publicado en 2006

Absence of NOTCH1 gene mutations in MALT lymphomas

scientific article published on 16 December 2011

Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab

artículo científico publicado en 2002

Acquired immunodeficiency syndrome-related cancer. A study model for the mechanisms contributing to the genesis of cancer

artículo científico publicado en 2001

Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment

article

Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients

artículo científico publicado en 2015

Age and Gender-Related Pretreatment Quality of Life Profiles in Patients with Higher-Risk Myelodysplastic Syndromes. Establishing Benchmark Data from an International Study ⬇️

artículo científico publicado en 2015

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.

artículo científico publicado en 2011

Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma

artículo científico publicado en 2012

Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma

article

An Integrated Analysis of Cardio-Vascular Adverse Events of Carfilzomib, Cyclophosphamide and Dexamethasone in Elderly Newly Diagnosed Myeloma Patients Enrolled in 3 Phase I/II Trials ⬇️

scholarly article

An anomalous case of acute coronary syndrome: the unexpected autoimmune duo.

artículo científico publicado en 2015

An update on: molecular genetics of high-risk chronic lymphocytic leukemia

scientific article published on 30 November 2019

Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis

artículo científico publicado en 2011

Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis.

artículo científico publicado en 2012

Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection

artículo científico publicado en 2005

Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders.

artículo científico publicado en 2006

Analysis of the Early Clonal Dynamics in Ibrutinib-Treated Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado en 2016

Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia

artículo científico publicado en 2010

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

artículo científico publicado en 2011

Analysis of the coding genome of diffuse large B-cell lymphoma

artículo científico publicado en 2011

Anaplastic large cell lymphoma and acquired angioedema: a novel association?

artículo científico publicado en 2002

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.

artículo científico publicado en 2010

Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity

scientific article published on 27 January 2020

Apoptosis and Proliferation Synergistically Determine Overall Survival in Chronic Lymphocytic Leukemia (CLL) ⬇️

artículo científico publicado en 2015

Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia

artículo científico publicado en 2015

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

artículo científico publicado en 2013

Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial

artículo científico publicado en 2011

Atypical Chronic Myeloid Leukemia: Where Are We Now?

scientific article published on 18 September 2020

Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program

scientific article published on 14 July 2011

B-cell Posttransplant Lymphoproliferative Disorders in Heart and/or Lungs Recipients: Clinical and Molecular-Histogenetic Study of 17 Cases from a Single Institution

artículo científico publicado en 2006

B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage

artículo científico publicado en 2011

BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas ⬇️

artículo científico publicado el 15 de septiembre de 1997

BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma

scientific article published on 04 February 2014

BCL3 translocation in CLL with typical phenotype: assessment of frequency, association with cytogenetic subgroups, and prognostic significance

artículo científico publicado en 2010

Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.

artículo científico publicado en 2002

Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia.

artículo científico publicado en 2015

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

artículo científico publicado en 2014

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).

artículo científico publicado en 2012

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

artículo científico publicado en 2018

Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma.

artículo científico publicado en 2010

Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease

artículo científico publicado en 2018

Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications

scientific article published on 29 August 2019

Biologic aspects of human immunodeficiency virus-related lymphoma

artículo científico publicado en 1992

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia

artículo científico publicado en 2020

Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome

artículo científico publicado en 2008

Biological and clinical significance of stereotyped B-cell receptors in chronic lymphocytic leukemia ⬇️

artículo científico publicado el 1 de diciembre de 2010

Biology and treatment of Richter syndrome.

artículo científico publicado en 2018

Bone marrow necrosis complicating post-transplant lymphoproliferative disorder: resolution with rituximab

artículo científico publicado en 2007

Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients. ⬇️

artículo científico publicado en 2009

Bortezomib, Melphalan, Prednisone and Thalidomide Followed by Maintenance with Bortezomib and Thalidomide (VMPT-VT) for Initial Treatment of Elderly Multiple Myeloma Patients: Updated Follow-up and Impact of Prognostic Factors ⬇️

scholarly article

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival

artículo científico publicado en 2014

Burkitt's lymphoma: historical background and recent insights into classification and pathogenesis

artículo científico publicado en 2000

CD38 Expression Marks CLL Cells with Invasive Properties ⬇️

artículo científico publicado en 2010

CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?

artículo científico publicado en 2008

CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival

artículo científico publicado en 2009

CD49d Is Overexpressed in Trisomy 12 Chronic Lymphocytic Leukemia by an Epigenetic-Dependent Transcriptional Control ⬇️

scholarly article

CD49d expression in chronic lymphocytic leukemia: a prognostic parameter and a therapeutic target

artículo científico publicado en 2008

CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.

artículo científico publicado en 2008

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism

article

CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia

artículo científico publicado en 2014

CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

artículo científico publicado en 2020

CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells ⬇️

scholarly article

CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death

artículo científico publicado en 2011

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies.

artículo científico publicado en 2018

Can Reed-Sternberg cells of classic Hodgkin's disease be considered B-cells?

artículo científico publicado en 1999

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

artículo científico publicado en 2015

Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup.

artículo científico publicado en 2017

Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies

artículo científico publicado en 2020

Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR.

artículo científico publicado en 2016

Cellular and molecular mechanisms conditioning the accumulation of resting neoplastic cells in B-lymphocyte chronic lymphatic leukemia ⬇️

artículo científico publicado el 1 de junio de 1991

Central Nervous System (CNS) Relapse In a Population of 143 Patients (Pts) with Mantle Cell Lymphoma (MCL) From Two Centers ⬇️

scholarly article

Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia

artículo científico publicado en 2020

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

artículo científico publicado en 2015

Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma

artículo científico publicado en 2002

Characterization of a novel human surface molecule selectively expressed by mature thymocytes, activated T cells and subsets of T cell lymphomas

artículo científico publicado en 1999

Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.

artículo científico publicado en 2006

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies

artículo científico publicado en 2014

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

artículo científico publicado en 2017

Chronic lymphocytic leukaemia: a step ahead in the journey toward eradication

artículo científico

Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features

artículo científico publicado en 2003

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2018

Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma.

artículo científico publicado en 2018

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group

artículo científico publicado en 2014

Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands

artículo científico publicado en 2009

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

artículo científico publicado en 2014

Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.

artículo científico publicado en 2012

Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond

artículo científico publicado en 2016

Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia

artículo científico publicado en 2014

Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia

artículo científico publicado en 2016

Clinical implications of the molecular genetics of chronic lymphocytic leukemia

artículo científico publicado en 2013

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

artículo científico publicado en 2013

Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene

artículo científico publicado en 2011

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

artículo científico publicado en 2020

Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia

artículo científico publicado en 2015

Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia

artículo científico publicado en 2012

Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia.

artículo científico publicado en 2018

Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.

artículo científico publicado en 2013

Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk

artículo científico publicado en 2011

Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia

artículo científico publicado en 2017

Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

artículo científico publicado en 2006

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

artículo científico publicado en 2017

Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network

artículo científico publicado en 2015

Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases

artículo científico publicado en 2020

Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain

artículo científico publicado en 2013

Comprehensive Characterization of NOTCH1 Mutational Status in Chronic Lymphocytic Leukemia: Clinical Relevance of Subclonal Mutations and Mutation Types ⬇️

artículo científico publicado en 2016

Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study

article

Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies

scientific article published on 28 November 2019

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

artículo científico publicado en 2015

Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications

artículo científico publicado en 2019

Cyclin-dependent kinase inhibitor seliciclib shows in vitro activity in diffuse large B-cell lymphomas.

artículo científico publicado en 2007

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

artículo científico publicado en 2015

Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia.

artículo científico publicado en 2016

Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype

artículo científico publicado en 2011

Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma ⬇️

artículo científico publicado el 1 de octubre de 1992

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

artículo científico publicado en 2012

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

artículo científico publicado en 2013

Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature.

artículo científico publicado en 2010

Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.

artículo científico publicado en 2013

Differences in the expression of apoptotic proteins in Burkitt's lymphoma cell lines: potential models for screening apoptosis-inducing agents

artículo científico publicado en 2004

Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome

artículo científico publicado en 2012

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

artículo científico publicado en 2016

Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

scientific article published on 24 January 2019

Differential Distribution Of Recurrent Gene Mutations In Subsets Of Chronic Lymphocytic Leukemia Patients With Stereotyped B-Cell Receptors: Results From A Multicenter Project Of The European Research Initiative On CLL In A Series Of 2482 Cases ⬇️

artículo científico publicado en 2013

Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture.

artículo científico publicado en 2003

Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach

scientific article published on 01 December 2002

Diffuse large B-cell lymphoma genotyping on the liquid biopsy

artículo científico publicado en 2017

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

artículo científico publicado en 2011

Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation

artículo científico publicado en 2019

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.

artículo científico publicado en 2012

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study

artículo científico publicado en 2009

Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development.

artículo científico publicado en 2005

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

scientific article published on 04 July 2019

E2A Transcriptionally Regulates CD38 Expression In Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado en 2010

EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player ⬇️

scholarly article

Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment

artículo científico publicado en 2020

Early stage chronic lymphocytic leukaemia carrying unmutated IGHV genes is at risk of recurrent infections during watch and wait

article

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial

artículo científico publicado en 2019

Efficacy and Safety of Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma Based on Cytogenetic Risk Status: Subgroup Analysis from the Phase 3 Study Endeavor (NCT01568866) ⬇️

artículo científico publicado en 2015

Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study ⬇️

artículo científico publicado en 2018

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.

artículo científico publicado en 2010

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.

artículo científico publicado en 2018

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

scientific article published on 24 September 2020

Eltrombopag for the Treatment of Aplastic Anemia in Europe ⬇️

artículo científico publicado en 2018

Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor

artículo científico publicado en 2014

Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia

artículo científico publicado en 2013

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

artículo científico publicado en 2021

Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders

artículo científico publicado en 2008

Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival

artículo científico publicado en 2015

Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions ⬇️

artículo científico publicado el 14 de noviembre de 1997

European education corridors: opportunity for academic solidarity

artículo científico publicado en 2020

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.

artículo científico publicado en 2015

Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease.

artículo científico publicado en 1999

Expression of Mutated IGHV3-23 Genes in Chronic Lymphocytic Leukemia Identifies a Disease Subset with Peculiar Clinical and Biological Features

article

Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1.

artículo científico publicado en 2002

Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease

artículo científico publicado en 2002

Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism ⬇️

artículo científico publicado en 2014

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia

artículo científico publicado en 2014

Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A.

artículo científico publicado en 2015

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).

artículo científico publicado en 2015

FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.

artículo científico publicado en 2016

Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients

scientific article published on 26 November 2020

Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System

artículo científico publicado en 2024

Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients

scientific article published on 25 February 2020

Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas.

artículo científico publicado en 2003

Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation

artículo científico publicado en 2004

Functional Effects Of NOTCH1 Mutations In Chronic Lymphocytic Leukemia Patients ⬇️

artículo científico publicado en 2013

Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia

artículo científico publicado en 2016

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

artículo científico publicado en 2016

Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.

artículo científico publicado en 2003

Genetic Mechanisms of Immune Escape in Diffuse Large B Cell Lymphoma ⬇️

scholarly article

Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies

artículo científico

Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations ofBCL6: Implications for disease pathogenesis and histogenesis

artículo científico publicado en 1999

Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia

artículo científico publicado en 1997

Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia

artículo científico publicado en 1997

Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness

scientific article published on 18 February 2014

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

artículo científico publicado en 2021

Genetic pathways and histogenetic models of AIDS-related lymphomas.

artículo científico publicado en 2001

Genetics of follicular lymphoma transformation

artículo científico publicado en 2014

Genome Wide-DNA Profiling of HIV-Related Non-Hodgkin Lymphomas: Implications for Disease Pathogenesis and Histogenesis. ⬇️

artículo científico publicado en 2007

Genome wide DNA-profiling of HIV-related B-cell lymphomas

artículo científico publicado en 2009

Genome-Wide Analysis Reveals Frequent Inactivating Mutations of Acetyltransferase Genes In B-Cell Lymphoma ⬇️

artículo científico publicado en 2010

Genome-Wide DNA Profiling Identifies a Stable Profile Although with Aberrations Targeting the Fibroblast Growth Factor Pathway in Hairy Cell Leukemia. ⬇️

scholarly article

Genome-Wide Promoter Methylation Of Hairy Cell Leukemia (HCL) ⬇️

scholarly article

Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion

article

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.

artículo científico publicado en 2011

Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.

artículo científico publicado en 2013

Genome-wide DNA profiling of HIV-related B-cell lymphomas

artículo científico publicado en 2013

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

scientific article published on 29 November 2010

Genome-wide high resolution DNA profiling of hairy cell leukaemia

artículo científico publicado en 2013

Genome-wide promoter methylation of hairy cell leukemia

scientific article published on 01 February 2019

Genomic Aberrations Dramatically Improve The Strong Prognostic Impact Of IGHV Mutational Status In Chronic Lymphocytic Leukemia (CLL) ⬇️

scholarly article

Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma

scientific article published on 28 August 2011

Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma

article

Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

artículo científico publicado en 2006

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

artículo científico publicado en 2010

Genomic profiles of MALT lymphomas: variability across anatomical sites

artículo científico publicado en 2011

Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas

Gimema Registry of Conception/Pregnancy in Adult Italian Patients Diagnosed with Chronic Myeloid Leukemia (CML): Report on 166 Outcomes ⬇️

artículo científico publicado en 2018

Globalisation of clinical trials and ethics of benefit sharing

artículo científico publicado en 2014

Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells ⬇️

artículo científico publicado el 1 de junio de 1992

HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia

scientific article published on 09 July 2019

HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism

artículo científico publicado en 2013

Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatment.

artículo científico publicado en 2006

Health-Related Quality of Life Profile and Request of Prognostic Information on Survival At the Time of Diagnosis in Patients with High-Risk Myelodysplastic Syndromes ⬇️

scholarly article

Health-Related Quality of Life in Patients with Primary Immune Thrombocytopenia (pITP): Investigating Differences Amongst Newly Diagnosed, Persistent and Chronic Pitp Patients ⬇️

artículo científico publicado en 2015

Health-Related Quality of Life in Patients with Primary Immune Thrombocytopenia Compared with the General Population ⬇️

scholarly article

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

artículo científico publicado en 2016

Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship

artículo científico publicado en 2011

High Efficacy of Lenalidomide Plus R-CHOP (R2CHOP) Combination in First Line Treatment of Activated B-Cell (ABC) DLBCL Defined Using Gene-Expression Prophyling: A Combined Analysis from Two Phase 2 Trials ⬇️

artículo científico publicado en 2018

High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.

artículo científico publicado en 2008

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

artículo científico publicado en 2012

High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi s

artículo científico publicado en 2011

High-Throughput Sequencing For The Identification Of NOTCH1 mutations In Early Stage Chronic Lymphocytic Leukemia: Biological and Clinical Implications ⬇️

artículo científico publicado en 2013

High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications

artículo científico publicado en 2014

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

artículo científico publicado en 2020

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

scientific article published on 30 July 2020

Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

artículo científico publicado en 2002

IGH Repertoire Analysis In Multiple Myeloma (MM): Lack of Intra-Disease Homology and Occasional Clustering with Sequences of Other B-Cell Neoplasms Sharing Identical Geographical Origin ⬇️

scholarly article

IGHD3-3fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia

artículo científico publicado en 2012

II. Challenges in the management of post-transplant lymphoproliferative disorder

artículo científico

Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado en 2019

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado en 2015

Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance.

artículo científico publicado en 2014

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Preliminary Results of the Unit Study. ⬇️

artículo científico publicado en 2012

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Results of the Unit Study ⬇️

scholarly article

Immunogenetics features and genomic lesions in splenic marginal zone lymphoma

artículo científico publicado en 2010

Immunoglobulin (Ig) Variable Gene Usage Identifies a Subset of Unmutated Chronic Lymphocytic Leukemia (CLL) Patients Expressing 51p1-Like alleles and a Particularly Unfavorable Prognostic Outcome. ⬇️

artículo científico publicado en 2004

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases

scientific article published on 30 July 2018

Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL).

artículo científico publicado en 2006

Impact of Complete Response on Survival with Either Autologous Stem Cell Transplantation or Conventional Chemotherapy: Results of a Pooled Analysis of 5 Phase III Trials in Newly Diagnosed Multiple Myeloma Patients ⬇️

scholarly article

Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study

artículo científico publicado en 2015

Impact of Prior Treatment on Patients with Relapsed Multiple Myeloma Treated with Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in a Subgroup Analysis of the Phase 3 Endeavor Study (NCT01568866) ⬇️

artículo científico publicado en 2015

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry

artículo científico publicado en 2024

Impact of Treatment Intensification According to Patient Prognosis: A Pooled Analysis of 3 Randomized Phase III Trials ⬇️

artículo científico publicado en 2016

Impact of the host genetic background on prognosis of chronic lymphocytic leukemia

scientific article published on 01 February 2010

In Vitro Activity of SYK and BCR-ABL Inhibitors in Aggressive Lymphomas. ⬇️

scholarly article

In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.

artículo científico publicado en 2011

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

artículo científico publicado en 2011

Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency.

artículo científico publicado en 2004

Inclusion of Patient's Self-Reported Fatigue into a Standard Laboratory Risk Classification Enhances Survival Prediction in Patients with Advanced Myelodysplastic Syndromes ⬇️

scholarly article

Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide

artículo científico publicado en 2017

Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology

scientific article published on 02 May 2019

Inherited genetic susceptibility to monoclonal B-cell lymphocytosis

artículo científico publicado en 2010

Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?

artículo científico publicado en 2016

Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array

artículo científico publicado en 2011

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia

scientific article published on 15 January 2019

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

artículo científico publicado en 2013

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

artículo científico publicado en 2011

Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia

artículo científico publicado en 2016

Integrin distribution and cytoskeleton organization in normal and malignant monocytes

artículo científico publicado en 1990

Intensive Chemotherapy Does Not Prolong Survival Compared to 5-Azacitidine in Patients Aged 70 Years or More with Untreated Acute Myeloid Leukemia ⬇️

artículo científico publicado en 2012

Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.

artículo científico publicado en 2015

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

artículo científico publicado en 2016

Intermittent Imatinib (INTERIM) Treatment of Patients with Ph+ Chronic Myeloid Leukemia in Complete Cytogenetic Response: Cytogenetic and Molecular Data At One Year ⬇️

scholarly article

International Prognostic Score (IPS-A) for Patients with Early Stage Chronic Lymphocytic Leukemia

scholarly article

International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia

artículo científico publicado en 2020

Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance

artículo científico publicado en 2009

Investigating Preferences and Factors Associated with Involvement In Treatment Decision-Making In Newly Diagnosed Patients with High-Risk Myelodysplastic Syndromes: An International Multicenter Study ⬇️

artículo científico publicado en 2010

Investigational drugs for the treatment of diffuse large B-cell lymphoma

artículo científico publicado en 2020

Involvement of the bcl-6 gene in AIDS-related lymphomas

artículo científico publicado el 1 de enero de 1997

Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease?

artículo científico publicado en 2004

Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases

artículo científico publicado en 2014

JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders.

artículo científico publicado en 2006

JAK2V617F Mutation in Leukaemic Transformation of Philadelphia Negative Chronic Myeloproliferative Disorders. ⬇️

scholarly article

JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophilia

scientific article published on 23 July 2007

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study

scientific article published on 19 September 2019

KSHV/HHV8 Doesnʼt Play a Significant Role in the Development of Plasmablastic Lymphoma of the Oral Cavity

article

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated polyclonal body cavity effusions that mimic primary effusion lymphomas

artículo científico publicado en 2006

Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma

artículo científico publicado en 2005

Lack of Prognostic Significance of the Conventional and Novel Prognostic Markers in Trisomy 12 Chronic Lymphocytic Leukemia (CLL) ⬇️

scholarly article

Large Genomic Aberrations Are Independent Prognosticators of A Shorter Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia (CLL) Patients with A Normal FISH ⬇️

scholarly article

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome

scientific article published on 05 August 2019

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial

artículo científico publicado en 2014

Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi

artículo científico publicado en 2013

Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

artículo científico publicado en 2013

Liquid Biopsy As a Tool for Monitoring the Genotype of Diffuse Large B-Cell Lymphoma ⬇️

artículo científico publicado en 2015

Liquid biopsy in lymphoma

scholarly article by Davide Rossi et al published 1 April 2019 in Haematologica

Long Term Follow-up of Ph+ CML Patients Achieving Complete Cytogenetic Response (CCgR) with Interferon Based Therapy - GIMEMA Protocol CML0509 ⬇️

artículo científico publicado en 2011

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma.

artículo científico publicado en 2017

Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial

artículo científico publicado en 2018

Low Bax/Bcl-2 Ratio and NOTCH1 Mutations Represent Powerful and Synergistic Adverse Prognostic Factors within Trisomy 12 Chronic Lymphocytic Leukemia (CLL) ⬇️

scholarly article

Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome

artículo científico publicado en 2010

Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience

artículo científico publicado en 2015

Lymphocytosis and ibrutinib treatment of CLL

artículo científico publicado en 2014

Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing ⬇️

scholarly article

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis

artículo científico publicado en 2014

MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53wild-type CLL with a poor cytotoxic response to Nutlin-3.

artículo científico publicado en 2010

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia

artículo científico publicado en 2012

MYC network mutations in high-risk chronic lymphocytic leukaemia

artículo científico publicado en 2014

Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia.

artículo científico publicado en 2017

Mechanisms of Adaptation to Ibrutinib in High Risk Chronic Lymphocytic Leukemia ⬇️

scholarly article

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

artículo científico publicado en 2010

Messengers of cell death: apoptotic signaling in health and disease.

artículo científico publicado en 2003

Methods for Measuring ctDNA in Lymphomas

artículo científico publicado en 2019

Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy

artículo científico

Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.

artículo científico publicado en 2014

Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial

artículo científico publicado en 2014

Molecular Analysis of Posttransplant Lymphoproliferative Disorders (PTLD) of Donor Origin Occuring in Liver Transplant Patients. ⬇️

artículo científico publicado en 2005

Molecular History of Richter Syndrome: Origin From a Common Ancestor Cell Already Present at Chronic Lymphocytic Leukemia Diagnosis ⬇️

artículo científico publicado en 2010

Molecular Lesions Of Signalling Pathway Genes In Indolent B-Cell Lymphoproliferations Mimicking Splenic Marginal Zone Lymphoma ⬇️

artículo científico publicado en 2013

Molecular Subtypes of Splenic Marginal Zone Lymphoma (SMZL) Are Associated with Distinct Pathogenic Mechanisms and Outcomes - Interim Analysis of the IELSG46 Study ⬇️

artículo científico publicado en 2018

Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.

artículo científico publicado en 2008

Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

article

Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort.

artículo científico publicado en 2010

Molecular bases of chronic lymphocytic leukemia in light of new treatments

artículo científico

Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients

artículo científico publicado en 2009

Molecular genetics of high-risk chronic lymphocytic leukemia

artículo científico publicado en 2012

Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis

artículo científico publicado en 2002

Molecular histogenesis of plasmablastic lymphoma of the oral cavity

artículo científico publicado en 2002

Molecular histogenesis of posttransplantation lymphoproliferative disorders

scientific article published on 07 August 2003

Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.

artículo científico publicado en 2011

Molecular investigation of the cytokines produced by normal and malignant B lymphocytes

artículo científico publicado el 1 de febrero de 1992

Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features

artículo científico publicado en 2014

Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.

artículo científico publicado en 2000

Molecular pathogenesis of HIV-associated lymphomas

artículo científico publicado en 1992

Molecular pathogenesis of chronic lymphocytic leukemia

artículo científico publicado en 2012

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

artículo científico publicado en 2015

Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia

artículo científico publicado en 2009

Monocytes/Macrophages Are the Major Targets of the CCL3 Chemokine Produced by CD38+CD49d+ Chronic Lymphocytic Leukemia Cells. ⬇️

scholarly article

Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38+CD49d+chronic lymphocytic leukaemia cells

scientific article published on 21 March 2010

Most immunoglobulin heavy chain switch mu rearrangements in B-cell chronic lymphocytic leukemia are internal deletions

artículo científico publicado en 2002

Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia

artículo científico publicado en 2010

Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.

artículo científico publicado en 2011

Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O· production in cancer cells

article

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.

artículo científico publicado en 2017

Mutations at 3' Untranslated Region (3'UTR) of NOTCH1 Are Associated with Low CD20 Expression Levels in Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado en 2016

Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia

scientific article published on 26 May 2017

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

artículo científico publicado en 2012

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

artículo científico publicado en 2011

NF10 Project: An International, Prospective, Observational Study Of Patients With Indolent Non-Follicular Lymphoma. Analysis Of First 215 Patients ⬇️

scholarly article

NOTCH1 Mutated IGHV Unmutated Chronic Lymphocytic Leukemia Cells Are Characterized By a Constitutive Overexpression of Nucleophosmin-1 and Ribosome-Associated Components ⬇️

artículo científico publicado en 2014

NOTCH1 Mutations Are Associated with Low CD20 Expression in Chronic Lymphocytic Leukemia: Evidences for a NOTCH1-Mediated Epigenetic Regulatory Mechanism ⬇️

artículo científico publicado en 2014

NOTCH1 Stabilization By PEST Mutations Enhances IgM-Mediated Activity in Chronic Lymphocytic Leukemia ⬇️

scholarly article

NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.

artículo científico publicado en 2017

NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.

artículo científico publicado en 2014

NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL

artículo científico publicado en 2011

NOTCH1, SF3B1 and BIRC3 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients Requiring First-LINE Treatment: Correlation with Biological Parameters and Response to Treatment ⬇️

artículo científico publicado en 2012

NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.

artículo científico publicado en 2014

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.

artículo científico publicado en 2012

Nicotinamide Promotes Apoptosis In Chronic Lymphocytic Leukemia through Activation of the p53/Mir-34a/SIRT1 Tumor Suppressor Network ⬇️

scholarly article

Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network

artículo científico publicado en 2011

Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms

scientific article published on 28 April 2010

Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma ⬇️

artículo científico publicado en 2018

Novel Gene Mutations In Chronic Lymphocytic Leukemia: Prevalence and Clinical Implications In A Series Of 3185 Cases - Initial Results From The European Research Initiative On CLL ⬇️

artículo científico publicado en 2013

Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses

scientific article published on 24 April 2019

Nucleophosmin-1 and Ribosome-Associated Components Are Constitutively Overexpressed in NOTCH1 Mutated IGHV Unmutated CLL ⬇️

artículo científico publicado en 2012

Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2001

Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia

artículo científico

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study

scientific article published on 30 January 2018

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies

scientific article published on 07 February 2019

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

artículo científico publicado en 2017

Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib within a Named Patient Program (NPP) in Italy. a Real-Life Retrospective Study ⬇️

scholarly article

Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions.

artículo científico publicado en 2017

Outcome of therapy-related myeloid neoplasms treated with azacitidine

artículo científico publicado en 2012

Overall Survival and Subgroup Analysis from a Randomized Phase III Study of Intravenous Rigosertib Versus Best Supportive Care (BSC) in Patients (pts) with Higher-Risk Myelodysplastic Syndrome (HR-MDS) after Failure of Hypomethylating Agents (HMAs) ⬇️

scholarly article

PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization

artículo científico publicado en 2014

Pathobiology of primary mediastinal B-cell lymphoma

artículo científico publicado en 2003

Patient-Reported Fatigue, Functional Aspects and Quality of Life in Elderly Patients with High-Risk Myelodysplastic Syndromes. Evidence From a Large Prospective International Study. ⬇️

scholarly article

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

artículo científico publicado en 2017

Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?

artículo científico

Pattern of Care in Indolent Non Follicular Lymphoma: A Report from NF10 Project, an International, Prospective, Observational Study Coordinated By the Fondazione Italiana Linfomi ⬇️

artículo científico publicado en 2015

Peripheral Stem Cell Mobilization with Chemotherapy + G-CSF Priming in a Large Series of Patients with Lymphoma Candidates to Autologous Transplantation. An Analysis of Baseline and Ongoing Predictors of Failure or Suboptimal Stem Cell Collection. ⬇️

artículo científico publicado en 2009

Ph-Negative Hematopoiesis Emerging After Successful Treatment of Chronic Myeloid Leukemia Displays Severe and Persistent Telomeric Loss Which Is Particularly Prominent in Patients with Acquired Cytogenetic Abnormalities. ⬇️

artículo científico publicado en 2009

Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia

artículo científico publicado en 2015

Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial

artículo científico publicado en 2016

Phase 2 Study of Monotherapy Galunisertib (LY2157299 Monohydrate) in Very Low-, Low-, and Intermediate-Risk Patients with Myelodysplastic Syndromes ⬇️

artículo científico publicado en 2015

Phase II Multicenter Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndrome. ⬇️

artículo científico publicado en 2009

Phase II Multicentric Explorative Study of Intermittent Imatinib (IM) Treatment (INTERIM) in Elderly Patients with Ph+ Chronic Myeloid Leukemia (CML) Who Achieved a Stable Complete Cytogenetic Response (CCgR) with Standard IM Therapy. ⬇️

artículo científico publicado en 2009

Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia

artículo científico publicado en 2020

Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals

article

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis

artículo científico publicado en 2005

Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease

artículo científico publicado en 2009

Potential of BCL2 as a target for chronic lymphocytic leukemia treatment.

artículo científico publicado en 2018

Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding.

artículo científico publicado en 2018

Precision Medicine Management of Chronic Lymphocytic Leukemia

scientific article published on 10 March 2020

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score

artículo científico publicado en 2018

Predictive markers and driving factors behind Richter syndrome development

artículo científico publicado en 2011

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment

artículo científico publicado en 2018

Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers

artículo científico publicado en 2018

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe

artículo científico publicado en 2020

Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance

artículo científico publicado en 2007

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study ⬇️

artículo científico

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

artículo científico publicado en 2014

Primary cutaneous large B-cell lymphoma of the leg: Histogenetic analysis of a controversial clinicopathologic entity

article

Primary effusion lymphoma cell lines harbouring human herpesvirus type-8.

artículo científico publicado en 2000

Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities

artículo científico publicado en 2001

Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics

artículo científico publicado en 2002

Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins

artículo científico publicado en 2003

Prognostic Role of Transfusion Requirement and Validation of the IPSS Prognostic System in Myelodisplastic Syndromes. ⬇️

artículo científico publicado en 2006

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy

scientific article published on 03 July 2020

Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemia

artículo científico publicado en 2007

Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells

artículo científico publicado en 2010

Prognostic impact of monocyte count at presentation in mantle cell lymphoma

artículo científico publicado en 2013

Prognostic relevance of MYD88 mutations in CLL: the jury is still out.

artículo científico publicado en 2015

Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.

artículo científico publicado en 2011

Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study

artículo científico publicado en 2012

Prognostic value of clonal evolution identified by sequential FISH in untreated chronic lymphocytic leukaemia

artículo científico publicado en 2024

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

artículo científico publicado en 2015

Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option

artículo científico publicado en 2011

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.

artículo científico publicado en 2017

Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma

artículo científico publicado en 2013

Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance

artículo científico publicado en 2009

Protein Expression and Methylation Status of the CKI p21, p15 and p16 in Adult Acute Lymphoblastic Leukemia (ALL) Patients: Prognostic Implications. ⬇️

artículo científico publicado en 2006

PvuII RFLP in the cytovillin gene (VIL2) on human chromosome 6q

artículo científico publicado en 1992

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

publication published on 06 September 2021

R-CHOP21 Vs R-CHOP14 in 950 Diffuse Large B-Cell Lymphoma Patients: Results of a Multicentre Retrospective Study Form Italian Lymphoma Foundation (FIL) ⬇️

scholarly article

R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi

artículo científico publicado en 2013

RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications

artículo científico publicado en 2016

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

artículo científico publicado en 2015

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and [...]

artículo científico publicado en 2010

Reappraising Immunoglobulin Repertoire Restrictions in Chronic Lymphocytic Leukemia: Focus on Major Stereotyped Subsets and Closely Related Satellites ⬇️

artículo científico publicado en 2016

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

artículo científico publicado en 2017

Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations

artículo científico publicado en 2020

Relationship of Bone Marrow Blast (BMBL) Response to Overall Survival (OS) in Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS) Treated with Rigosertib after Failure of Hypomethylating Agents (HMAs) ⬇️

artículo científico publicado en 2014

Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience

artículo científico publicado en 2010

Reply to Aron P. Kater et al

artículo científico publicado en 2020

Reply to J. Wang et al

scientific article published on 12 February 2019

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia

artículo científico publicado en 2014

Richter syndrome

artículo científico

Richter syndrome: molecular insights and clinical perspectives

artículo científico publicado en 2009

Richter syndrome: pathogenesis and management

artículo científico publicado en 2016

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia

artículo científico publicado en 2018

Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial

artículo científico publicado en 2016

Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel

artículo científico publicado en 2011

Risk factors of central nervous system relapse in mantle cell lymphoma

artículo científico publicado en 2013

Rituximab, Bendamustine and Cytarabine (RBAC500) As Induction Therapy in Elderly Patients with Mantle Cell Lymphoma: Final Results of a Phase 2 Study from the Fondazione Italiana Linfomi ⬇️

scholarly article

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi

artículo científico publicado en 2016

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

artículo científico publicado en 2017

Role Of Interim,-PET In Poor Prognosis Young Patients With Diffuse Large B Cell Lymphoma At Diagnosis: Data From An Ancillary Study Of a Prospective Randomized Phase III Study (DLCL04) From the Fondazione Italiana Linfomi ⬇️

artículo científico publicado en 2013

Role of PET/CT in the Diagnostic Work-up of Patients with Chronic Lymphocytic Leukemia (CLL) and Clinical Signs of Disease Progression ⬇️

artículo científico publicado en 2012

SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response

artículo científico publicado en 2015

SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy ⬇️

artículo científico publicado en 2015

SNP-Arrays Provide New Insights Into the Pathogenesis of Richter Syndrome (RS) ⬇️

artículo científico publicado en 2011

SNP6 Array Better Defines Chronic Lymphocytic Leukemia (CLL) Prognostic Groups ⬇️

scholarly article

Safe and effective use of plerixafor plus G-CSF in dialysis-dependent renal failure

artículo científico publicado en 2010

Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia.

artículo científico publicado en 2011

Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia

article

Serial Echocardiographic Assessment of Patients (Pts) with Relapsed Multiple Myeloma (RMM) Receiving Carfilzomib and Dexamethasone (Kd) Vs Bortezomib and Dexamethasone (Vd): A Substudy of the Phase 3 Endeavor Trial (NCT01568866) ⬇️

scholarly article

Severe Telomeric Erosion In Ph-Negative Hematopoiesis After Successful CML Treatment: Association with Acquired Cytogenetic Lesions and Hematological Toxicity. ⬇️

artículo científico publicado en 2010

Significant Survival Improvement with Maintenance in Patients Achieving a Complete Response: Pooled Analysis of 4 Italian Phase III Trials in Newly Diagnosed Multiple Myeloma Patients ⬇️

artículo científico publicado en 2015

Simian AIDS-related lymphoma growth in severe combined immunodeficiency mice is independent of karyotypic abnormalities or Bcl-6 mutations

artículo científico publicado en 2002

Simian virus 40 infection in lymphoproliferative disorders

artículo científico publicado en 2003

Simian virus 40 infection in lymphoproliferative disorders

artículo científico publicado en 2003

Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia

artículo científico publicado en 2006

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

article by Andrea Rinaldi et al published 3 March 2010 in British Journal of Haematology

Single-Agent Ibrutinib Versus Chlorambucil-Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL): Results of a Cross-Trial Comparison ⬇️

artículo científico publicado en 2018

Single-Agent MOR208 in Relapsed or Refractory (R-R) Non-Hodgkin's Lymphoma (NHL): Results from Diffuse Large B-Cell Lymphoma (DLBCL) and Indolent NHL Subgroups of a Phase IIa Study ⬇️

scholarly article

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind ⬇️

artículo científico publicado en 2018

Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies

artículo científico publicado en 2018

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi

artículo científico publicado en 2018

Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia ⬇️

scholarly article

Splenic marginal zone lymphoma: a prognostic model for clinical use.

artículo científico publicado en 2006

Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

artículo científico publicado en 2009

Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma

artículo científico publicado en 2010

Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.

artículo científico publicado en 2014

Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations ⬇️

artículo científico publicado el 15 de diciembre de 1992

Subregional mapping of 8 single copy loci to chromosome 6 by fluorescence in situ hybridization

artículo científico publicado en 1994

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study

scientific article published on 14 April 2020

Syk expression patterns differ among B-cell lymphomas

scientific article published on 07 April 2010

TP53 Mutations, the Most Frequent Genetic Lesion in Richter Syndrome, Represent An Independent Predictor of Survival Post Transformation. ⬇️

artículo científico publicado en 2009

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

artículo científico publicado en 2020

Tailored Approaches for Refined Prognostication in Chronic Lymphocytic Leukemia Patients with Mutated Versus Unmutated Immunoglobulin Receptors ⬇️

artículo científico publicado en 2016

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

artículo científico publicado en 2018

TaqI RFLP in the interferon gamma receptor 1 gene (IFNGR1) on human chromosome 6q.

artículo científico publicado en 1992

Targeting TP53 in chronic lymphocytic leukemia

artículo científico publicado en 2020

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

artículo científico publicado en 2009

Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.

artículo científico publicado en 2012

The Coding Genome of Nodal Marginal Zone Lymphoma Reveals Recurrent Molecular Alterations of PTPRD and Other Jak/Stat Signaling Genes ⬇️

artículo científico publicado en 2014

The Genotype of MLH1 Is An Independent Predictor of Outcome In Diffuse Large B-Cell Lymphoma Treated with R-CHOP: a Training-Validation Study ⬇️

artículo científico publicado en 2010

The Host Genetic Background of DNA Repair Mechanisms Represents An Independent Predictor of Progression and Survival in Diffuse Large B-Cell Lymphoma Treated with R-CHOP. ⬇️

artículo científico publicado en 2009

The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells.

artículo científico publicado en 2012

The Molecular Profile of Richter Syndrome Predicts Survival From Transformation: The Role of Clonal Relationship ⬇️

scholarly article

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

scientific article published on 03 March 2009

The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection

artículo científico publicado en 2014

The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.

artículo científico publicado en 2013

The Registro Italiano Trombocitemie (GIMEMA Project): Preliminary Analysis of the First 801 Enrolled Patients. ⬇️

artículo científico publicado en 2006

The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.

artículo científico publicado en 2015

The clinical implications of gene mutations in chronic lymphocytic leukaemia

artículo científico publicado en 2016

The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development

artículo científico publicado en 2012

The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

article

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

artículo científico publicado en 2009

The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

artículo científico publicado en 2011

The genetics of nodal marginal zone lymphoma

scientific article published on 22 June 2016

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.

artículo científico publicado en 2015

The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

artículo científico publicado en 2010

The human marginal zone B cell

artículo científico publicado en 2003

The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis

artículo científico publicado en 2000

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

artículo científico publicado en 2017

The mutator pathway is a feature of immunodeficiency-related lymphomas

scholarly article

The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

artículo científico publicado en 2009

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

artículo científico publicado en 2009

The role of cytokines in the pathogenesis and management of AIDS-related lymphomas.

artículo científico publicado en 2000

The spectrum of genetic defects in chronic lymphocytic leukemia

artículo científico publicado en 2012

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.

artículo científico publicado en 2014

Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients

artículo científico publicado en 2003

Tracking the biological risk of coronary artery disease in HIV-infected individuals: the case of circulating endothelial progenitor cells

artículo científico publicado en 2011

Transient monoclonal expansion of CD8+/CD57+ T-cell large granular lymphocytes after primary cytomegalovirus infection.

artículo científico publicado en 2007

Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.

artículo científico publicado en 2004

Treatment with the Thrombopoietin (TPO)-Receptor Agonist Romiplostim in Thrombocytopenic Patients (Pts) with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndrome (MDS): Results of a Randomized, Double-Blind, Placebo(PBO)-Controlled Study ⬇️

scholarly article

Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia

artículo científico publicado en 2014

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas apoptosis in Burkitt's lymphomas with loss of multiple pro-apoptotic proteins.

artículo científico publicado en 2003

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.

artículo científico publicado en 2013

Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms

artículo científico publicado en 2016

Unmutated IGHV1-69/D3-16/J3 Stereotyped HCDR3 Rearrangements (Subset 6) Are Associated with Indolent Disease Course and Have Outcome Independent of Mutational Status In Early Stage CLL (Rai 0) ⬇️

artículo científico publicado en 2010

Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib

artículo científico publicado en 2018

Updating Long-Term Outcome of Intermittent Imatinib (INTERIM) Treatment in Elderly Patients with Ph+-CML ⬇️

scholarly article

Usage of IGHV4-39 with Stereotypic B Cell Receptor Is An Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome ⬇️

artículo científico publicado en 2008

Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera

artículo científico publicado en 2007

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab

artículo científico publicado en 2018

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab

scientific article published on 16 September 2020

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

artículo científico publicado en 2016

Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies

scientific article published on 07 August 2019

Vemurafenib Plus Rituximab in Hairy Cell Leukemia: A Promising Chemotherapy-Free Regimen for Relapsed or Refractory Patients ⬇️

artículo científico publicado en 2016

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia

artículo científico publicado en 2021

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

artículo científico publicado en 2015

Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCd) in Newly Diagnosed Multiple Myeloma Patients: A Phase I- II Study ⬇️

scholarly article

Whole Transcriptome Sequencing In Refractory T-Cell Acute Lymphoblastic Leukemia ⬇️

scholarly article

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

artículo científico publicado en 2015

miRNAs involvement in the pathogenesis of Richter's syndrome

scholarly article by Katrien Van Roosbroeck et al published 8 November 2018 in Haematologica

rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda